West Pharmaceutical Services, Inc.’s Stock Price Drops to $342.76, Experiencing a 3.62% Decline: Is it Time to Buy?

West Pharmaceutical Services, Inc. (WST)

342.76 USD -12.88 (-3.62%) Volume: 0.67M

West Pharmaceutical Services, Inc.’s stock price is currently at 342.76 USD, experiencing a trading session decline of -3.62%, with a trading volume of 0.67M. Despite a year-to-date decrease of -2.66%, WST remains a key player in the pharmaceutical sector.

Latest developments on West Pharmaceutical Services, Inc.

Recent stock price movements of West Pharmaceutical Services Inc (NYSE:WST) have been influenced by various events. Private Advisor Group LLC acquired shares, while Brown Advisory Inc. increased its position in the company. However, Trillium Asset Management LLC sold a significant number of shares. Analysts have also cut Q2 2024 EPS estimates for West Pharmaceutical Services Inc. The stock soared to a 52-week high, prompting discussions on whether it is time to cash out. Investors are comparing WST to HSIC to determine the better value option, impacting the stock’s movement today.

West Pharmaceutical Services, Inc. on Smartkarma

Analysts at Baptista Research have been closely following West Pharmaceutical Services Inc, a leading provider of innovative solutions for injectable drug administration. In their report titled “West Pharmaceutical Services: Contract Manufacturing Expansion & Other Major Drivers,” the analysts highlight the company’s strong start to the year 2024 despite market challenges. They delve into factors impacting the company’s performance and conduct an independent valuation using a Discounted Cash Flow methodology. The report aims to evaluate key drivers that could influence the company’s stock price in the near future.

Furthermore, Baptista Research‘s analysis in the report “West Pharmaceutical Services: Regulatory Shift Driving Increased Demand for High Value Products! – Major Drivers” focuses on the company’s fourth quarter 2023 earnings conference call. The report emphasizes West Pharmaceutical Services’ base growth in 2023 driven by expanding customer demand for high value products and contract manufacturing services. The analysts highlight the regulatory shift driving increased demand for the company’s offerings, positioning them for growth in the coming quarters.

A look at West Pharmaceutical Services, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

West Pharmaceutical Services Inc has a positive long-term outlook based on its Smart Scores. With a strong score in Growth and Momentum, the company is positioned for future success in the healthcare industry. Additionally, its Resilience score indicates a stable foundation for weathering market fluctuations. While the Value and Dividend scores are more moderate, the overall outlook for West Pharmaceutical Services Inc remains favorable.

West Pharmaceutical Services, Inc. is a company that focuses on providing valuable services in the healthcare market. With a solid reputation for designing and manufacturing packaging components, researching and developing drug delivery systems, and offering contract laboratory services, West Pharmaceutical Services Inc plays a crucial role in bringing new drug therapies and healthcare products to global markets. With a balanced set of Smart Scores, the company is well-equipped to navigate the challenges of the industry and continue its growth trajectory.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma